To evaluate the role of different vasomotor stimuli for the measurement of cerebrovascular vasomo tor reactivity (VMR), 47 patients (i.e., 93 hemispheres) with various degrees of internal carotid artery (ICA) oc clusive disease were studied. Patients were divided into clinical [asymptomatic, transient ischemic attack (TIA) or completed stroke] as well as angiological subgroups. Low-grade or high-grade unilateral ICA lesions were compared to bilateral ICA occlusive disease. Relative flow velocity changes within the middle cerebral artery were measured by means of transcranial Doppler during hyper-and hypocapnia (VMRTOT)' during hypercapnia alone (VMRco), and after injection of 1 g acetazolamide
(VMRACE)' VMR was expressed as the percentage change in flow velocity after stimulus application as com pared with flow velocity at rest. There was a close and statistically highly significant correlation of CO2-induced with acetazolamide-induced VMR (r = 0.69 in VMRTOT versus VMRACE and 0.79 in VMRco , versus VMRACE; p < 0.0001; linear regression), indicating a strong similarity Measurement of cerebrovascular reserve helps to identify patients with reduced cerebral perfusion pressure and quantifies the hemodynamic impact of extracranial occlusive lesions of the brain-supplying arteries (Bullock et al. , 1984; Bishop et al. , 1986; Ringelstein et al., 1988; Ringelstein, 1989) . The idea underlying all current approaches is to apply va sodilating stimuli to the resistance vessels of the brain and, at the same time, to measure CBF of the vasodilatative effects of CO2 and acetazolamide on cerebral arteries. Both stimulation techniques highly sig nificantly differentiated between asymptomatic patients and those with TIA or completed stroke. Angiological subgroups were separated best by the acetazolamide test. Reclassification of patients into angiological subgroups by linear discriminant analysis was equally good with all three methods. We conclude that both acetazolamide and CO2-induced stimulation of the cerebral vasomotors are valid techniques to measure reduction in perfusion reserve due to extracranial cerebrovascular occlusive dis ease. Acetazolamide has the advantage of being indepen dent of the patient's cooperation. However, it has the disadvantage of increasing the intracranial pressure and not permitting evaluation of the vasoconstrictor capabil ities of the cerebral vasculature. Key Words: Acetazol amide-Cerebrovascular response-Extracranial occlu sive disease-Hypercapnia-Hypocapnia-Intracranial hemodynamics.
changes by either regional CBF techniques (Harper and Glass, 1966; Norrving et al. , 1982; Bullock et al. , 1984) or transcranial Doppler (TCD) sonogra phy (Widder et al. , 1986; Ringelstein, 1989b) . The relative increase in CBF due to decreasing imped ance of the brain vasculature directly reflects the spontaneous tone of the arterioles. In cases where cerebral vasomotors are already dilated to compen sate for a pathology-induced reduction in cerebral perfusion pressure, exogenous vasodilating stimuli will no longer be effective (Gibbs et al. , 1984; Rin gel stein et al. , 1988) .
There is good reason to believe that the diameter of the large basal cerebral arteries will be scarcely, if at all, affected by the above-mentioned stimuli (Huber and Handa, 1967; Bradac et al. , 1976) . Thus, intraindividual shifts in blood flow velocity reflect changes in CBF within the vascular territory under study (Kirkham et al. , 1986) .
While the measurement of vasomotor reactivity (VMR) with capnic (C02) stimuli depends on pa tient compliance and ability to stand the respiration work during hyperventilation, the action of the ac etazolamide stress test is independent of coopera tion. This compound would therefore be of partic ular interest for the evaluation of cerebral VMR in patients with acute brain disorders, like ischemic stroke. In the present study, we measured the effect of capnic stimuli on flow velocity within the cere bral vasculature in patients with various degrees of extracranial occlusive disease and compared these findings with measurements in the same patients after administration of acetazolamide. As an inde pendent criterion of the diagnostic quality of both tests, we calculated their ability to differentiate be tween various independently defined subgroups of patients.
METHODS

Recruitment of patients
Forty-seven patients, 40 men and 7 women, with uni lateral or bilateral internal carotid artery (ICA) lesions of various degrees of severity were consecutively collected for this study. Patients were 44-83 years old (median 62 years). Fourteen completely asymptomatic patients were included. They had routinely been checked for ICA le sions in our ultrasound laboratories because of peripheral occlusive disease, coronary heart disease, or bruits in the neck. If the patients had had a previous stroke, the time interval between measurement of cerebral VMR and the last ischemic event was at least 6 weeks. All patients gave their informed consent to acetazolamide injections sub sequent to routine CO2 testing. Patients with windows in the temporal plane bilaterally insufficient for insonation of the basal cerebral arteries were excluded (n = 12). The same applied to patients with chronic occlusive lung dis ease (n = 3) and congestive heart failure (n = 2). Finally, 93 middle cerebral artery (MCA) territories jointly termed "hemispheres" were considered for this study. In one case, unilateral extracranial-intracranial bypass surgery had been performed, and MCA flow velocity measure ments were not possible on this side. All further state ments refer to these 93 hemispheres and not to patients.
The hemispheres were divided into subgroups accord ing to both clinical and angiological criteria.
Clinical subgroups. Fifty-six hemispheres were asymp tomatic in terms of both history as well as neurological findings (see Table 1 ). Twenty hemispheres had suffered transient ischemic attacks (TIAs) or amaurosis fugax cor responding to the vascular trunk under study, and 13 had suffered a complete stroke of either minor or major se verity. In two cases, neurological history was equivocal, and patients could not be clearly allotted to one of the clinical subgroups. Analysis of clinical findings thus re fers to only 89 hemispheres.
Angiological subgroups. Evaluation and quantification of the extracranial ICA lesions were performed by con- tinuous wave Doppler sonography (n = 47; see below) and also by intraarterial two-plane digital subtraction ar teriography via a transfemoral route in a subset of 18 patients (see below). Lesions in the vertebrobasilar sys tem were not considered here.
On the basis of these continuous wave Doppler or ar teriographic findings, both ICAs were classified as having either occlusion (0), high-grade stenosis (H); i.e., a re duction in cross-sectional area of ?80%, low-grade ste nosis (L); i.e., reduction in cross-sectional area of <80% but ?60%, or no stenosis (N); which means normal lu men or at least no lesion detectable by extracranial con tinuous wave Doppler ultrasound or reduction in cross sectional area of <60%. With respect to bilateral ICA findings, five angiological subgroups of patients were considered: ICA with no stenosis on the side under study irrespective of the situation on the contralateral ICA (N X); unilateral low-grade ICA stenosis irrespective of the contralateral ICA findings (L-X); ipsilateral high-grade ICA stenosis irrespective of the presence or severity of a contralateral ICA lesion (H-X); unilateral ICA occlusion with contralateral low-grade or no stenosis (O-LN); uni lateral ICA occlusion with contralateral high-grade steno sis or occlusion (O-HO) (see Table 2 ).
Laboratory tests
Evaluation of extracranial occlusive disease in neck arteries. A detailed methodology for continuous wave Doppler examination of the extracranial brain arteries has been described previously (Spencer, 1986; von Reutern, 1987; Ringelstein, 1989a) . Findings at the ICAs in the neck were quantified according to the angiological subgroups (see above). B-mode detection of nonstenosing plaques was not considered here.
Arteriographic approach. Eighteen patients (38%) were subjected to bilateral selective cerebral angiography of the common carotid artery via transfemoral catheter study with the digitial subtraction technique. The injec tion volume was 5-7 ml of nonionic contrast medium. Patients were subjected to angiography within 2 weeks at the latest after Doppler diagnosis. At least two views were taken and these were independently judged by two experienced neuroradiologists. In total, 36 extracranial carotid arteries could be analyzed. To prevent nonstenos ing plaques and wall irregularities in the ICA being over diagnosed angiographically, only a cross-sectional lumen narrowing of at least 60% (corresponding to -30% reduc tion in lumen diameter) was considered to be stenotic. The formula recently published by Zwiebel et al. (1982) was applied to quantify the degree of stenosis. In three carotid arteries, discrepancies between the sonographic and angiographic quantification of the lesion occurred. In these cases, only the arteriographic findings were consid ered for further analysis.
CO2 test. Details of noninvasive assessment of CO2induced cerebral vasomotor response have been pub lished elsewhere (Ringelstein et al., 1988) . Briefly, blood flow velocity was measured using TCD during CO2 acti vation with each subject supine. The TCD transducer was placed over one temporal plane, and the MCA under study was insonated at a depth of 50--55 mm. End-tidal CO2 volume percent (C02 vol%) was recorded by an in frared CO2 analyzer (Capnolog; Datex Instrumentarium OY, Helsinki, Finland). Blood pressure and heart rate were also monitored noninvasively (Dinamap Ergometer; Criticon, Tampa, FL, U.S.A.). Flow velocity measure ments were performed while the subject breathed room air (normocapnia), or subsequently air with CO2 concen trations of 6, 5, 4, 3, and 2%, and during at least three increasing intensities of hyperventilation. When the mean MCA blood flow velocity, end-tidal CO2 volume percent arterial blood pressure, and heart rate reached steady states, a sequence of -20 cardiac cycles was recorded on tape for a more precise off-line, computer-assisted deter mination of mean MCA blood flow velocities. During in halation of room air, MCA flow velocity was taken as 100%, and changes in mean blood flow velocity during inhalation of various CO2 concentrations or during hyper ventilation were expressed as percent deviation. These relative blood flow velocities were plotted against the cor responding end-tidal CO2 volume percent. No attempt was made to convert relative blood flow velocities to ab solute values. A tangent-hyperbolic function gave the best curve fit of data. The distance between the two as ymptotes was thought to reflect the responsiveness of the cerebral vasculature to capnic stimuli, i.e., the CO2induced VMR (Fig. IA) . The intraindividual reproduci bility of CO2-induced VMR measurements within the MCA territory had been shown to be high (Ringelstein et al., 1988) , with ranges of VMR values of < 10%. No such data are yet available for the acetazolamide test.
Two different parameters of CO2 reactivity were used for comparisons: Only the hypercapnic reactivity span of the vasomotors was considered (VMRco,; Fig. lB) or total CO2-induced VMR reactivity (VMR�oT)' "Total" refers to the inclusion of both the hypercapnic and the hypocapnic part of the test (Fig. IA) . This was done to evaluate the additional information derived from the in ferior hypocapnic branch of the S-shaped reactivity curve.
Acetazolamide test. The next day, patients were sub jected to a similar test by stimulating the cerebral vaso-
.. motors with 1 g acetazolamide i. v. A venous line was inserted into the cubital vein, and the MCA under study was insonated prior to injection with the patient at rest and supine. Approximately six sweeps of pulse waves on the screen, corresponding to -20--30 heart cycles, were used to calculate the mean MCA flow velocity. The probe was kept in place and the MCA was continuously in sonated. A second flow velocity measurement was per formed in the same way 15 min after injection of acet azolamide. This time interval seemed to be necessary since Holl et al. (1991) had demonstrated a plateauing of regional CBF occurring 15 ± 5 min after administration of acetazolamide, lasting for at least 20 min. The MCA flow velocity value at rest was set at 100%, and the relative increase in flow velocity after acetazol amide was calculated according to where V A means MCA flow velocity 15 min after acet azolamide injection and V R means MCA flow velocity at rest. The result was called VMR A C E (ACE being acet azolamide-induced). It should be emphasized that the ac etazolamide test depended on this two-point measure ment alone (Fig. 1 C) .
AV%
Adverse effects of acetazolamide were recorded by careful history taking and interrogation of the patients.
Statistical analysis
To estimate the agreement of both techniques, CO2related VMR parameters were statistically compared with those of the acetazolamide test by calculating linear re gression and Pearson correlation coefficients. The Mann Whitney U test was used to evaluate the ability of both parameters to differentiate between various clinical or an giological subgroups. The sequentially rejective multiple test procedure of Holm (1979) was used to control the overall type I error level at 5% for each of the VMR parameters. Finally, we examined the ability of both methods to reclassify patients into their angiological sub groups by means of CO2-related or acetazolamide-related VMR values. This was done with separate linear discrim inant analyses for each of the VMR parameters. No at tempt was made to examine their joint classification prop erties. The number of correct reclassifications was used to indicate the validity of the various VMR tests.
RESULTS
The correlation coefficient r between acetazol amide stimulation and the complete CO2 test, in cluding hyper-and hypocapnia, was 0.693. It was highly significantly different from zero (p < 0.0001; Fig. 2A ). If VMR values measured during hyper capnia alone were related to the acetazolamide induced reactivity, this correlation was even slightly higher and r reached 0.785 (p < 0.0001; Fig.  2B ).
All three parameters of cerebral VMR were equivalent in their ability to differentiate between various clinical subgroups, i.e. , to separate symp tomatic and asymptomatic hemispheres. This result held true even when provision for multiple testing with Holm's procedure was made. This is illus trated in Table 3 . The difference between patients with asymptomatic carotid arteries and those with amaurosis fugax or TlA was highly significant (p < 0.01). A highly significant VMR difference could also be obtained between asymptomatic hemi spheres and those having had a complete stroke (p < 0.01).
The acetazolamide test, however, turned out to do best in separating angiological subgroups (Fig.   3 ). The differences for VMRACE between subgroups N-X and H-X, or L-X and H-X, or H-X and O-NL, or H-X and O-HO were all significant or even highly significant, also with Holm's procedure (Fig. 3B ). Both CO2 methods were slightly less sensitive in separating patients and failed, for instance, to dem onstrate statistically significant differences between various types of high-grade ICA lesions (Fig. 3A) . Table  4 ). The performance of hypercapnia-induced VMR alone was slightly worse and led to only 53 correct items.
Adverse effects of acetazolamide were transient facial numbness (n = 31), strange taste on the tongue (n = 23), light-headedness (n = 8), in creased diuresis (n = 7), and severe headache (n = 1).
DISCUSSION
The present study was performed to clarify whether CO2 and acetazolamide as vasodilative stimuli to the brain vasculature would be helpful in identifying patients with reduced cerebral perfusion pressure. We also wanted to investigate which of the tests would perform best in quantifying the re duction in perfusion reserve by using two indepen dent external criteria.
Several studies on regional CBF or TCD flow ve locity changes after acetazolamide (Vorstrup et aI. , 1986; Hojer-Pedersen, 1987; Sullivan et aI. , 1987; Bonte et aI. , 1988; Sorteberg et aI. , 1989) or follow ing CO2 stimulation (Harper and Glass, 1966; Sy mon et aI. , 1973; Norrving et aI. , 1982; Bullock et aI. , 1984; Gibbs et aI. , 1984; Bishop et aI. , 1986; Widder et aI. , 1986; Ringelstein et aI. , 1988) have been reported; comparisons of both techniques, however, have not yet been performed in patients with extracranial occlusive disease. In the present study, both types of vasomotor stimulation were directly compared by linear regression and discrim inant analysis. The clinical state of the patient (symptomatic versus asymptomatic hemispheres) and the severity of the extracranial occlusive dis ease served as independent clinical criteria for the J Cereb Blood Flow Metab, Vol. 12, No. 1, 1992 stroke, 0.0081 validity of the tests. As could be shown, the VMR after acetazolamide and that after CO2 stimulation revealed a highly significant correlation. Acetazol amide was as reliable as CO2 in differentiating clin ical subgroups. With respect to angiological sub groups, acetacolamide was slightly superior to CO2, but this difference was not substantial. During dis criminant analysis, acetazolamide was clearly as valid as the complete CO2 stress test. This latter finding deserves an explanatory comment. Linear discriminant analysis with reclassification of pa tients to angiological subgroups was not performed to replace the direct ultrasound or angiographic evaluation of the extracranial arteries by VMR mea surements as a more global hemodynamic parame ter, but only to objectively determine by statistical means which stimulation technique is superior in terms of its impact on cerebral perfusion pressure. The identical, though low, proportion of 58% cor rect reclassifications indicates that both stimulation techniques are equivalent in reflecting disturbed hemispheric hemodynamics.
Our findings are valid only for the intravenous injection of 1 g (2 vials) of acetazolamide. This dos age is necessary to achieve a supramaximal dilata tive effect on the cerebral resistance arteries and to completely exhaust the residual VMR span of the cerebral vasculature. The maximum effect of acet azolamide occurs 12-20 min after the injection (Holl et aI. , 1991) , with some subsequent plateauing for �20 min. During this period, TCD sonography or regional CBF measurements can be performed without haste. This makes acetazolamide easy to handle.
Potential sources of error should be noted. We observed that the acetazolamide-induced metabolic effect on the vasomotors may be counterbalanced by hyperventilation, particularly in young adults. The resulting hypocapnia would then counteract the expected increase in flow velocity or regional CBF. Patients should therefore be instructed to try to breathe constantly, or this source of error should be controlled by continuously monitoring the end-tidal CO2 volume percentage. Minor side effects to acet- azolamide were also observed, such as dizziness, congestion of the head, light-headedness, and head aches, but these did not limit our study. With respect to the particular cohort investi gated, there was amazingly little additional informa tion extractable from the hypocapnic part of the study. In a low-pressure vascular bed, one would expect the arterioles to become dilated for meta bolic reasons. The latter would prevent vasomotors from contracting during ventilatory hypocapnia. This could, in fact, be demonstrated in patients with ICA occlusions and moderate or severe reduction in perfusion pressure (Ringel stein et al., 1988) . In cases with only mild reduction in perfusion pres sure, however, the metabolic vasodilative force on the vasomotors was weak, and the vasoconstrictor stimulus of hypocapnia could be operative. The greatly varying severity of ICA lesion in this study might explain the relatively low impact of hypocap nia on VMR measurements in patients suffering from cerebrovascular occlusive disease.
In certain clinical settings, the hypocapnic branch of the CO2-induced VMR curve may be more mean ingful with respect to cerebral autoregulation than the hypercapnic response. In patients with blunt head trauma and intracranial hematomas, Klingel hofer and Sander (1991) recently demonstrated that reduction of the vasoconstrictor response to hypo capnia allowed a quite reliable prognosis of the final outcome. It is not possible, however, to investigate the vasoconstrictor potency of the cerebral vascu lature by means of acetazolamide since it has only dilatative effects. Furthermore, Wilkinson (1989) has warned about applying acetazolamide in such patients since it leads to an abrupt, marked increase in intracranial pressure.
The adverse effects of extracranial arterial occlu sive disease on CBF and intracranial hemodynam ics have previously been somewhat overestimated. The predominant mechanism of stroke is throm boembolic rather than a low blood flow effect. A small subgroup of patients, however, experience TlAs, low flow-induced brain infarctions, and/or progressive ischemic eye disease due to critically reduced perfusion pressure (Ringelstein et al., 1988) . These patients represent true cases of cere brovascular insufficiency in the strict sense that CBF cannot be sufficiently maintained even with recruitment of all available mechanisms for com pensation (Harper and Glass, 1966; N orrving et aI., 1982; Gibbs et aI., 1984; Vorstrup et aI., 1986; Wid der et aI., 1986; Hojer-Pedersen, 1987; Ringelstein et aI., 1988) . Such patients may benefit from thera peutic measures to improve large-vessel flow, such as extracranial-intracranial bypass surgery, carotid endarterectomy, or other recanalization tech niques, but these patients would not be expected to benefit from any form of anticoagulation treatment. Identification of this subgroup of stroke-prone indi viduals is based on the detection of an exhausted cerebrovascular reserve (N orrving et al., 1982; Gibbs et aI., 1984; Ringelstein et aI., 1988) . Whether reconstructive vascular surgery will, however, im prove the final outcome of patients with a preoper atively exhausted VMR remains to be demonstrated by prospective follow-up investigations.
In conclusion, the acetazolamide test was equiv alent to various types of CO2 testing or even mini mally superior in evaluating the hemodynamic ef fect of extracranial lesions in the ICA territory. For practical purposes, we prefer the acetazolamide test in the acute phase of cerebrovascular disease and also, with increasing frequency, for routine or re petitive examinations in the ultrasound laboratory in chronic cases. For certain scientific purposes, the complete CO2 test including hypocapnia still seems to be most informative since it also evaluates the vasoconstrictive capabilities of the cerebral vas culature.
